Digestive organ cancer
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with digestive organ cancer or precancerous lesion requiring standard therapy. 2. 20 years and more at informed consent. 3. Ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
Exclusion criteria: 1. Patients whose consent cannot be obtained. 2. Patients whose participation in the trial was judged to be inappropriate by the attending doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Association of perioperative cell free DNA amount and fragment length with postoperative complications. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Association of perioperative cell free DNA amount and fragment length with clinicopathological factors. 2. Association of perioperative cell free DNA amount and fragment length with operative procedure. 3. Association of perioperative cell free DNA amount and fragment length with recurrence and prognosis. 4. Association of perioperative cell free DNA amount and fragment length with frailty in patients older than 65 years. | — |
Countries
Japan
Contacts
Wakayama Medical University Second Department of Surgery